These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2565090)

  • 1. Neurohumoral changes during onset and offset of ovine heart failure: role of ANP.
    Fitzpatrick MA; Nicholls MG; Espiner EA; Ikram H; Bagshaw P; Yandle TG
    Am J Physiol; 1989 Apr; 256(4 Pt 2):H1052-9. PubMed ID: 2565090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptide responses to acute and chronic ventricular pacing in sheep.
    Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM
    Am J Physiol; 1996 Feb; 270(2 Pt 2):H594-602. PubMed ID: 8779835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic and neurohumoral response in heart failure produced by rapid ventricular pacing.
    Travill CM; Williams TD; Pate P; Song G; Chalmers J; Lightman SL; Sutton R; Noble MI
    Cardiovasc Res; 1992 Aug; 26(8):783-90. PubMed ID: 1451153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANP infusion in the treatment of heart failure and comparison with ACE inhibition.
    Fitzpatrick MA; Espiner EA; Ikram H; Nicholls MG; Bagshaw P; Yandle TG
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):536-43. PubMed ID: 1691381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide and sodium homeostasis in compensated heart failure.
    Lohmeier TE; Mizelle HL; Reinhart GA; Montani JP; Hord CE; Didlake RH
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1353-63. PubMed ID: 8945974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurohumoral regulation in heart failure].
    Riegger GA; Muders F; Luchner A
    Z Kardiol; 1996; 85 Suppl 6():205-10. PubMed ID: 9064967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conditions of secretion and peripheral effects of atrial natriuretic peptide in heart failure].
    Riegger AJ
    Z Kardiol; 1988; 77 Suppl 5():77-86. PubMed ID: 2975895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOCA administration and atrial natriuretic factor in dogs with chronic heart failure.
    Villarreal D; Freeman RH; Brands MW
    Am J Physiol; 1989 Sep; 257(3 Pt 2):H739-45. PubMed ID: 2528918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurohormonal assessment in heart failure: from the sophisticated laboratory to practical indications].
    Dei Cas L; Metra M; Visioli O
    G Ital Cardiol; 1993 Feb; 23(2):193-204. PubMed ID: 8098306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular actions of atrial natriuretic factor in sheep with cardiac failure.
    Parkes DG; Coghlan JP; Cooper EA; Routley M; McDougall JG; Scoggins BA
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):905-12. PubMed ID: 7826554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atrial natriuretic peptide in cardiac insufficiency].
    Riegger AJ
    Arzneimittelforschung; 1988 Mar; 38(3A):479-83. PubMed ID: 2969247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of atrial natriuretic peptide in long-term volume homeostasis.
    Lohmeier TE; Mizelle HL; Reinhart GA
    Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):55-61. PubMed ID: 7768035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
    Stevens TL; Burnett JC; Kinoshita M; Matsuda Y; Redfield MM
    J Clin Invest; 1995 Mar; 95(3):1101-8. PubMed ID: 7883958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
    Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep.
    Rademaker MT; Charles CJ; Espiner EA; Fisher S; Frampton CM; Kirkpatrick CM; Lainchbury JG; Nicholls MG; Richards AM; Vale WW
    J Am Coll Cardiol; 2002 Oct; 40(8):1495-505. PubMed ID: 12392842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ACE inhibition: mechanisms of cardioprotection in chronic experimental heart failure].
    Riegger AJ
    Klin Wochenschr; 1991; 69 Suppl 24():20-3. PubMed ID: 1830909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic, hormonal, and renal effects of (pro)renin receptor blockade in experimental heart failure.
    Rademaker MT; Yandle TG; Ellmers LJ; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2012 Sep; 5(5):645-52. PubMed ID: 22798523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide in congestive heart failure.
    Fyhrquist F; Tikkanen I
    Am J Cardiol; 1988 Jul; 62(2):20A-24A. PubMed ID: 2968757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated diuretic and natriuretic effects of atrial natriuretic peptide in rats with heart failure.
    Tikkanen T; Tikkanen I; Sariola H; Svartström-Fraser M; Fyhrquist F
    Horm Metab Res; 1989 Apr; 21(4):185-8. PubMed ID: 2526789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.